Covid-19 vaccination BNT162b2 temporarily impairs semen concentration and total motile count among semen donors

Posted on | Posted on John Murphy | Leave a Comment on Covid-19 vaccination BNT162b2 temporarily impairs semen concentration and total motile count among semen donors

Authors: Itai Gat,Alon Kedem,Michal Dviri,Ana Umanski,Matan Levi,Ariel Hourvitz,Micha Baum 17 June 2022 Abstract Background The development of covid-19 vaccinations represents a notable scientific achievement. Nevertheless, concerns have been raised regarding their possible detrimental impact on male fertility Objective To investigate the effect of covid-19 BNT162b2 (Pfizer) vaccine on semen parameters among semen donors (SD). Methods […]

The CDC says “severe reactions” to the COVID vaccines are rare. That’s not what we found.

Posted on | Posted on John Murphy | Leave a Comment on The CDC says “severe reactions” to the COVID vaccines are rare. That’s not what we found.

A new poll of Americans shows that 1% of people who get the jab (2M Americans over 18) are so seriously COVID vaccine injured that they are unable to hold a job. Authors: Steve Kirsch Jun 20, 2022 Executive summary The CDC has always maintained that severe reactions to the COVID vaccines are rare. Since I […]

Most long-COVID sufferers battle neurological symptoms, including some cognitive issues never seen before

Posted on | Posted on John Murphy | Leave a Comment on Most long-COVID sufferers battle neurological symptoms, including some cognitive issues never seen before

Authors: Jocelyn Solis-Moreira JUNE 20, 2022 https://www.braintomorrow.com/ People continue to experience neurological problems six months after recovering from a COVID-19 infection, finds a recent study from the University of California San Diego. In fact, scientists say most coronavirus long-haulers battle brain-related issues. The findings are part of a long-term study tracking the progression of neurological […]

This May Be the COVID Variant Scientists Are Dreading

Posted on | Posted on John Murphy | Leave a Comment on This May Be the COVID Variant Scientists Are Dreading

Authors: David Axe June 20, 2022 TDB COVID-19 cases are increasing again in the United Kingdom, potentially signaling a future surge in infections in the United States and other countries. A pair of new subvariants of the dominant Omicron variant—BA.4 and BA.5—appear to be driving the uptick in cases in the U.K. Worryingly, these subvariants seem […]

Israel sees 70% spike in number of seriously ill COVID patients within a week

Posted on | Posted on John Murphy | Leave a Comment on Israel sees 70% spike in number of seriously ill COVID patients within a week

‘It’s an unpredictable and unstable situation,’ says immune system expert Prof. Cyrille Cohen, urging lawmakers to ‘actively encourage herd immunity among the vulnerable’ Authors:  Times of Israel June 2022 The number of coronavirus patients in serious condition in Israel reached 140 on Friday, marking a near 70% rise since last week, with health experts warning […]

Laboratory Biomarkers for Diagnosis and Prognosis in COVID-19

Posted on | Posted on John Murphy | Leave a Comment on Laboratory Biomarkers for Diagnosis and Prognosis in COVID-19

Authors: Denise Battaglini, 1 , 2 , 3 Miquéias Lopes-Pacheco, 4 Hugo C. Castro-Faria-Neto, 5 Paolo Pelosi, 1 , 2 and Patricia R. M. Rocco 4 , 6 , 7 , * Front Immunol. 2022; 13: 857573.  Apr 27.  2022 doi: 10.3389/fimmu.2022.857573 PMCID: PMC9091347 PMID: 35572561 Abstract Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) causes a wide spectrum of clinical manifestations, with progression to multiorgan failure in the most severe cases. Several biomarkers can be altered […]

Pfizer Stops Enrollment in COVID-19 Pill Trial After Latest Results

Posted on | Posted on John Murphy | Leave a Comment on Pfizer Stops Enrollment in COVID-19 Pill Trial After Latest Results

Authors: Mimi Nguyen Ly June 16, 2022 The Epoch Times Paxlovid, a Pfizer COVID-19 pill, is seen manufactured in Ascoli, Italy, in this undated photo obtained by Reuters on Nov. 16, 2021. (Pfizer/Handout via Reuters) Pfizer has announced it will stop enrollment in a clinical trial for Paxlovid—its COVID-19 antiviral pill—for standard-risk COVID-19 patients after the latest results suggested […]

40-Year-Old British Columbia Man Diagnosed with Guillain-Barré Syndrome Is Awarded Compensation for Vaccine Injury (VIDEO)

Posted on | Posted on John Murphy | Leave a Comment on 40-Year-Old British Columbia Man Diagnosed with Guillain-Barré Syndrome Is Awarded Compensation for Vaccine Injury (VIDEO)

Authors: Jim Hoft Published June 16, 2022  The Gateway Pundit A 40-year-old father from British Columbia was one of the first people in Canada to be compensated after suffering an adverse reaction connected to the COVID-19 vaccine. Ross Wightman, a former pilot and realtor was diagnosed with Guillain-Barré Syndrome (GBS), which is a rare disorder in […]

Mask mandate and use efficacy in state-level COVID-19 containment

Posted on | Posted on John Murphy | Leave a Comment on Mask mandate and use efficacy in state-level COVID-19 containment

Authors: Damian D. Guerra, Daniel J. Guerra doi: https://doi.org/10.1101/2021.05.18.21257385 Abstract Background Containment of the COVID-19 pandemic requires evidence-based strategies to reduce transmission. Because COVID-19 can spread via respired droplets, many states have mandated mask use in public settings. Randomized control trials have not clearly demonstrated mask efficacy against respiratory viruses, and observational studies conflict on whether mask use predicts lower […]